| Oral direct-acting agent therapy for hepatitis C virus infection: a systematic review O Falade-Nwulia, C Suarez-Cuervo, DR Nelson, MW Fried, JB Segal, ... Annals of internal medicine 166 (9), 637-648, 2017 | 716 | 2017 |
| Hepatitis C guidance 2018 update: AASLD-IDSA recommendations for testing, managing, and treating hepatitis C virus infection AIHCVG Panel Clinical infectious diseases: an official publication of the Infectious …, 2018 | 360 | 2018 |
| Adverse interactions between antifungal azoles and vincristine: review and analysis of cases B Moriyama, SA Henning, J Leung, O Falade‐Nwulia, P Jarosinski, ... Mycoses 55 (4), 290-297, 2012 | 176 | 2012 |
| Understanding and addressing hepatitis C reinfection in the oral direct‐acting antiviral era O Falade‐Nwulia, MS Sulkowski, A Merkow, C Latkin, SH Mehta Journal of viral hepatitis 25 (3), 220-227, 2018 | 99 | 2018 |
| Public health clinic‐based hepatitis C testing and linkage to care in baltimore O Falade‐Nwulia, SH Mehta, J Lasola, C Latkin, A Niculescu, C O'Connor, ... Journal of viral hepatitis 23 (5), 366-374, 2016 | 75 | 2016 |
| Host factors dictate control of viral replication in two HIV-1 controller/chronic progressor transmission pairs RW Buckheit III, TG Allen, A Alme, M Salgado, KA O'connell, S Huculak, ... Nature communications 3 (1), 716, 2012 | 72 | 2012 |
| Barriers and facilitators of hepatitis C treatment uptake among people who inject drugs enrolled in opioid treatment programs in Baltimore O Falade-Nwulia, R Irvin, A Merkow, M Sulkowski, A Niculescu, Y Olsen, ... Journal of substance abuse treatment 100, 45-51, 2019 | 63 | 2019 |
| Comparative risk of liver-related mortality from chronic hepatitis B versus chronic hepatitis C virus infection O Falade-Nwulia, EC Seaberg, CR Rinaldo, S Badri, M Witt, CL Thio Clinical infectious diseases 55 (4), 507-513, 2012 | 58 | 2012 |
| Staying hepatitis C negative: a systematic review and meta‐analysis of cure and reinfection in people who inject drugs NH Latham, JS Doyle, AY Palmer, JW Vanhommerig, P Agius, ... Liver International 39 (12), 2244-2260, 2019 | 50 | 2019 |
| High hepatitis C cure rates among black and nonblack human immunodeficiency virus–infected adults in an urban center O Falade‐Nwulia, C Sutcliffe, J Moon, G Chander, T Wansom, J Keruly, ... Hepatology 66 (5), 1402-1412, 2017 | 47 | 2017 |
| A longitudinal study of vaccine hesitancy attitudes and social influence as predictors of COVID-19 vaccine uptake in the US C Latkin, L Dayton, J Miller, G Yi, A Balaban, B Boodram, M Uzzi, ... Human Vaccines & Immunotherapeutics 18 (5), 2043102, 2022 | 46 | 2022 |
| More than just availability: Who has access and who administers take-home naloxone in Baltimore, MD L Dayton, RE Gicquelais, K Tobin, M Davey-Rothwell, O Falade-Nwulia, ... PloS one 14 (11), e0224686, 2019 | 43 | 2019 |
| Racial disparities in overdose prevention among people who inject drugs L Dayton, K Tobin, O Falade-Nwulia, M Davey-Rothwell, A Al-Tayyib, ... Journal of Urban Health 97, 823-830, 2020 | 42 | 2020 |
| Incident hepatitis B virus infection in HIV-infected and HIV-uninfected men who have sex with men from pre-HAART to HAART periods: a cohort study O Falade-Nwulia, EC Seaberg, AE Snider, CR Rinaldo, J Phair, MD Witt, ... Annals of internal medicine 163 (9), 673-680, 2015 | 39 | 2015 |
| A randomized controlled trial of cash incentives or peer support to increase HCV treatment for persons with HIV who use drugs: the CHAMPS study KM Ward, O Falade-Nwulia, J Moon, CG Sutcliffe, S Brinkley, ... Open forum infectious diseases 6 (4), ofz166, 2019 | 38 | 2019 |
| Primary care providers knowledge, attitude and practices related to hepatitis C screening and treatment in the oral direct acting antiviral agents era O Falade-Nwulia, A McAdams-Mahmoud, R Irvin, A Niculescu, KR Page, ... Journal of community medicine & health education 6 (5), 2016 | 38 | 2016 |
| Behavioral and attitudinal correlates of trusted sources of COVID-19 vaccine information in the US CA Latkin, L Dayton, JR Miller, G Yi, A Jaleel, CC Nwosu, C Yang, ... Behavioral sciences 11 (4), 56, 2021 | 34 | 2021 |
| Genomic diversity of SARS-CoV-2 during early introduction into the Baltimore–Washington metropolitan area PM Thielen, S Wohl, T Mehoke, S Ramakrishnan, M Kirsche, ... JCI insight 6 (6), 2021 | 30 | 2021 |
| Patient-centred models of hepatitis C treatment for people who inject drugs: a multicentre, pragmatic randomised trial AH Litwin, PJ Lum, LE Taylor, SH Mehta, JI Tsui, J Feinberg, AY Kim, ... The Lancet Gastroenterology & Hepatology 7 (12), 1112-1127, 2022 | 28 | 2022 |
| Liver disease, HIV and aging O Falade-Nwulia, CL Thio Sexual health 8 (4), 512-520, 2011 | 28 | 2011 |
